Healthcare / Medical Care FacilitiesASX
$1.88
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $326.6M · quality 75.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
27/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.9B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-10.3%
↓Gross Margin
100.0%
↑Debt/Equity
0.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.3%
FCF CAGR
+1.8%
FCF margin
42.4%
FCF / Net income
-0.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $713.8M · net income $-436.8M · FCF $302.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $713.8M | $713.8M | $650.5M | $560.1M | $503.8M |
| Net Income | $-436.8M | $-436.8M | $4.8M | $257.8M | $692.9M |
| EBITDA | $-27.2M | $-27.2M | $-50.7M | $458.0M | $788.4M |
| EPS | — | — | 0.01 | 0.47 | 1.23 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -16.6% | -16.6% | -10.7% | -3.5% | 0.4% |
| Net Margin | -61.2% | -61.2% | 0.7% | 46.0% | 137.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.40 | 0.40 | 0.58 | 0.50 | 0.99 |
| Current Ratio | 1.33 | 1.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $302.9M | $302.9M | $486.3M | $326.6M | $287.3M |
| Returns | |||||
| ROE | -10.3% | -10.3% | 0.1% | 5.5% | 20.2% |
| Valuation | |||||
| P/B | 0.45 | 0.45 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 9.7% | 9.7% | 16.1% | 11.2% | — |
| EPS Growth | — | — | -98.6% | -61.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-22.2%
Start / end P/E
n/dx → n/dx
EPS bridge
0.01 → n/d
Residual
-22.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.